Picture of Alpine Immune Sciences logo

ALPN — Alpine Immune Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Press Digest: Wall Street Journal - April 11

April 11 (Reuters) - The following are the top stories
in the Wall Street Journal. Reuters has not verified these
stories and does not vouch for their accuracy.

    - Vertex Pharmaceuticals  VRTX.O  has agreed to acquire
Alpine Immune Sciences  ALPN.O  for $4.9 billion in cash,
bolstering its portfolio on kidney diseases as deals in
biotechnology continue to heat up.

    - Four Paramount Global  PARA.O  directors are expected to
leave the board soon, as the Shari Redstone-controlled
entertainment company discusses a merger with Skydance Media.

    - Former Trump Organization Chief Financial Officer Allen
Weisselberg was sentenced to five months in jail for lying
during a civil-fraud investigation into the former president.

    - KPMG's Netherlands unit agreed to pay a $25 million fine
over claims of exam cheating and misinforming investigators, the
largest monetary penalty imposed on an auditing firm by the
Public Company Accounting Oversight Board.

    - Macy's  M.N  appointed two new independent directors, a
move that ended a proxy fight with Arkhouse Management that was
seeking to oust most of the 15-person board and to buy the
company.

    - U.S. presidential candidate Cornel West has tapped Melina
Abdullah as his vice presidential running mate in his long-shot
bid.

 (Compiled by Bengaluru newsroom)
 ((globalnewsmonitoring@thomsonreuters.com))

Recent news on Alpine Immune Sciences

See all news